Bide Pharmatech Past Earnings Performance
Past criteria checks 2/6
Bide Pharmatech has been growing earnings at an average annual rate of 16.2%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 24.7% per year. Bide Pharmatech's return on equity is 4%, and it has net margins of 7.3%.
Key information
16.2%
Earnings growth rate
12.8%
EPS growth rate
| Pharmaceuticals Industry Growth | 10.9% |
| Revenue growth rate | 24.7% |
| Return on equity | 4.0% |
| Net Margin | 7.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Bide Pharmatech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,098 | 80 | 269 | 64 |
| 30 Jun 24 | 1,101 | 78 | 267 | 63 |
| 31 Mar 24 | 1,102 | 99 | 261 | 59 |
| 31 Dec 23 | 1,092 | 110 | 254 | 60 |
| 30 Sep 23 | 1,050 | 161 | 217 | 52 |
| 30 Jun 23 | 988 | 171 | 196 | 51 |
| 31 Mar 23 | 909 | 157 | 182 | 50 |
| 31 Dec 22 | 834 | 146 | 171 | 43 |
| 30 Sep 22 | 768 | 129 | 165 | 39 |
| 30 Jun 22 | 707 | 114 | 165 | 34 |
| 31 Mar 22 | 649 | 101 | 155 | 34 |
| 31 Dec 21 | 606 | 98 | 148 | 32 |
| 31 Dec 20 | 391 | 59 | 108 | 18 |
| 31 Dec 19 | 249 | -1 | 111 | 22 |
| 31 Dec 18 | 163 | -19 | 90 | 13 |
Quality Earnings: 688073 has high quality earnings.
Growing Profit Margin: 688073's current net profit margins (7.3%) are lower than last year (15.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688073 has become profitable over the past 5 years, growing earnings by 16.2% per year.
Accelerating Growth: 688073's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688073 had negative earnings growth (-50.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-2.5%).
Return on Equity
High ROE: 688073's Return on Equity (4%) is considered low.